At Xellia, we aspire to be a sustainable business that adds value to society and actively partners with key stakeholders in addressing global challenges. We integrate sustainability in all parts of our value chain.
Xellia is committed to conducting business responsibly and we continuously strive to reduce our impact on the environment by manufacturing responsibly. In addition, a key element of our business is to ensure patient safety and product safety through high-level quality and safe manufacturing practices. Furthermore, we ensure business is conducted ethically by protecting human rights through safe working conditions, fighting corruption and ensuring fair labor at all Xellia sites and in the supply chain.
By being a member of the United Nations Global Compact, we are guided by its ten principles and the Sustainable Development Goals (SDGs), to ensure we are on the right path to achieve a better and more sustainable future.
Furthermore, Xellia joined organizations such as AMR Industry Alliance, Medicines for Europe, End Drug Shortages Alliance and the Pharmaceutical Supply Chain Initiative, all with the aim of engaging ourselves with diverse stakeholders in the industry to strengthen our sustainability efforts.
Our sustainability framework is based on three focus areas: Environmental, Social and Governance (ESG). Long-term targets are developed within each focus area. The targets collectively cover the entire value chain and include:
Environmental
Minimize the environmental impact from our own manufacturing and extended supply chain by focusing on sustainable solutions and carbon emission reduction.
Social
Providing life-saving treatments to patients globally. Supporting the health and wellbeing of our staff and creating a diverse and inclusive work environment. Reducing inequalities globally through philanthropic engagement.
Governance
Conducting business responsibly in all countries we operate in. Continue to run the business in a transparent and accountable way. Ensuring policies and Code of Conduct are followed by all employees, suppliers and leaders. To further promote ethical business conduct, Xellia became a member of the Pharmaceutical Supply Chain Initiative (PSCI) in 2022. With this membership, Xellia engages with fellow members and advocates for increased transparency in the supply chain and promoting responsible supply chain practices.